![Kenneth Newman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Newman
Technik-/Wissenschafts-/F&E-Leiter bei
IONIS PHARMACEUTICALS, INC.
Profil
Dr. Kenneth B. Newman is a Senior Vice President-Clinical Development at Ionis Pharmaceuticals, Inc. Dr. Newman was previously employed as a Chief Medical Officer by Verona Pharma Ltd., a Chief Development Officer by Mesoblast, Inc., a Chief Medical Officer & EVP-Clinical Development by Acton Pharmaceuticals, Inc., a Vice President by Boehringer Ingelheim Corp., and an Executive Director by Forest Laboratories, Inc. He received his undergraduate degree from Duke University, an MBA from Carl H.
Lindner College of Business and a doctorate degree from The University of Texas Health Science Center at Houston.
Aktive Positionen von Kenneth Newman
| Unternehmen | Position | Beginn |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Kenneth Newman
| Unternehmen | Position | Ende |
|---|---|---|
| VERONA PHARMA PLC | Technik-/Wissenschafts-/F&E-Leiter | 30.04.2018 |
Mesoblast, Inc.
 Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Corporate Officer/Principal | 01.12.2014 |
Acton Pharmaceuticals, Inc.
 Acton Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2013 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Corporate Officer/Principal | 01.01.2009 |
| FOREST LABORATORIES, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Kenneth Newman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
25
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Health Technology |
Acton Pharmaceuticals, Inc.
Acton Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
Verona Pharma Plc
 Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
Carl H. Lindner College of Business
 Carl H. Lindner College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Health Science Center at Houston
 The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
